Media Room
Second Quarter 2026 Results
Second quarter 2026 results will be reviewed by management during a live audio webcast with the financial community on July 30, 2026. The presentation will be followed by a Q&A session.
Press Releases
July 24, 2026
Press Release: Sanofi announces decision not to submit amlitelimab in atopic dermatitis for global regulatory reviews
July 21, 2026
Press Release: Sanofi evolves its Executive Committee to support its next strategic chapter
July 10, 2026
Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector
Contact Our Media Team
You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.
Publications
October 2025
Annual Report on Form 20-F
Annual Report on Form 20-F 2025
October 2025
Annual Report on Form 20-F
Viewer XBRL ESEF (fr)
July 2025
Half-year Financial Reports
Half Year 2025 Financial Report
July 2025
Half-year Financial Reports
Half year 2025 financial report XBRL package